These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7856267)

  • 1. [Serum antibodies against brain tissue in multiple sclerosis patients: a frequent phenomenon in chronic progressive, but not relapsing disease course].
    Henneberg A; Mayle DM; Pfau JU; Hartmann P; Elsner U; Kornhuber HH
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):593-6. PubMed ID: 7856267
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of the immunofluorescence and immunodiffusion methods for the detection of anti-brain antibodies in the sera of patients with central nervous system diseases].
    Gannuszkina IW; Weinrauder H; Zirnowa IG
    Neuropatol Pol; 1983; 21(2):183-90. PubMed ID: 6415514
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IgG and IgM ganglioside GM1 antibodies in patients with multiple sclerosis.
    Zaprianova E; Majtényi K; Deleva D; Mikova O; Filchev A; Sultanov B; Kolyovska V; Sultanov E; Christova L; Kmetska X; Georgiev D
    Ideggyogy Sz; 2004 Mar; 57(3-4):94-9. PubMed ID: 15133910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum antibodies against brain tissue in patients with multiple sclerosis].
    Rysková O; Vejbora O
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(4):407-11. PubMed ID: 3249926
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
    Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
    Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunofluorescence in the diagnosis of autoimmune diseases and other diseases of the immune system].
    Seelig HP
    Ric Clin Lab; 1983; 13 Suppl 2():45-56. PubMed ID: 6230707
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [About "Multiple sclerosis and autoimmune diseases" ].
    Spadaro A; Valesini G
    Reumatismo; 2002; 54(1):68. PubMed ID: 12089618
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity.
    Dale RC; Church AJ; Surtees RA; Lees AJ; Adcock JE; Harding B; Neville BG; Giovannoni G
    Brain; 2004 Jan; 127(Pt 1):21-33. PubMed ID: 14570817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge.
    Mavragani CP; Patronas N; Dalakas M; Moutsopoulos HM
    J Rheumatol; 2007 Feb; 34(2):341-5. PubMed ID: 17304657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenesis of multiple sclerosis: implications for treatment.
    Waldron-Lynch F; Hennessy MJ
    Ir Med J; 2004 Jan; 97(1):5-6. PubMed ID: 15055909
    [No Abstract]   [Full Text] [Related]  

  • 15. [The significance of the autoantigenicity of nerve tissue elements in traumatic and vascular lesions of the brain].
    Gannushkina IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):172-7. PubMed ID: 4909281
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
    Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
    J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple sclerosis: advances in its pathogenesis].
    Godoy J; Court J
    Rev Med Chil; 1982 Jun; 110(6):581-4. PubMed ID: 6761822
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspects of humoral and cellular immunity in schizophrenia.
    Vartanian ME; Kolyaskina GI; Lozovsky DV; Burbaeva GS; Ignatov SA
    Birth Defects Orig Artic Ser; 1978; 14(5):339-64. PubMed ID: 80239
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune optic neuropathy.
    Riedel P; Wall M; Grey A; Cannon T; Folberg R; Thompson HS
    Arch Ophthalmol; 1998 Aug; 116(8):1121-4. PubMed ID: 9715702
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis.
    Niederwieser G; Buchinger W; Bonelli RM; Berghold A; Reisecker F; Költringer P; Archelos JJ
    J Neurol; 2003 Jun; 250(6):672-5. PubMed ID: 12796827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.